Hartmut Jaeschke holds a Ph.D. degree. He works as a Professor and Chair of the Department of Pharmacology, Toxicology, and Therapeutics at the University of Kansas Medical Center, Kansas, Kan, USA, since 2006. After receiving his Ph.D. degree in toxicology from the University of Tuebingen, Tübingen, Germany, in 1983, he did his postdoctoral work at the University of Tuebingen and at Baylor College of Medicine in Houston, Tex, USA. Since 1987, he held faculty positions at Baylor (1987–1992), at the University of Arkansas for Medical Sciences, Little Rock, Ark, USA (1999–2002), and at the University of Arizona, Tucson, Ariz, USA (2002–2006). In addition, he spent 6 years in the pharmaceutical industry (The Upjohn Co. and Pharmacia & Upjohn Co.), from 1992 to 1998. He has published more than 250 peer-reviewed papers, invited reviews, and commentaries in the areas of liver toxicology and pathophysiology. In the past, Dr. Jaeschke served on the Editorial Boards of American Journal of Physiology: Liver and Gastrointestinal Physiology, Gastroenterology, and Toxicology Letters and was an Associate Editor for Hepatology (2002–2006) and Liver International (2007–2012). He currently serves as a Member of the Editorial Boards of Toxicological Sciences, Hepatology, Journal of Hepatology, Shock, World Journal of Gastroenterology, and several other journals. He is a Member of 9 national and international scientific societies including the Society of Toxicology and the American Association for the Study of Liver Diseases. His major research interests include mechanisms of xenobiotic-induced hepatotoxicity and tissue repair with focus on acetaminophen; role of oxidant stress, adhesion molecules, cytokines, and chemokines in the mechanisms of inflammatory liver injury in models of hepatic ischemia-reperfusion injury, obstructive cholestasis, and endotoxin shock; and signaling pathways of apoptosis and necrosis in hepatocytes.
Biography Updated on 6 January 2013